Form 4 Tracker
Mineralys Therapeutics, Inc.
MLYS

25 insider filings · Latest: May 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 14, 2025Jul 14 8:23 PMRodman David Malcom
Proposed Sale
11,366$14.59$165.9K

View →

Jul 11, 2025Jul 11 8:11 PMCongleton Jon
Proposed Sale
15,884$14.51$230.4K

View →

Jul 11, 2025Jul 11 8:10 PMLevy Adam Scott
Proposed Sale
10,758$14.45$155.5K

View →

Jun 13, 2025Jun 13 8:23 PMRodman David Malcom
Proposed Sale
11,366$14.60$165.9K

View →

May 14, 2025May 14 8:24 PMRodman David Malcom
Proposed Sale
11,366$15.29$173.8K

View →

Apr 14, 2025Apr 14 8:11 PMRodman David Malcom
Proposed Sale
11,366$14.53$165.2K

View →

Apr 11, 2025Apr 11 8:10 PMLevy Adam Scott
Proposed Sale
10,757$12.06$129.7K

View →

Apr 11, 2025Apr 11 8:10 PMCongleton Jon
Proposed Sale
15,319$12.19$186.8K

View →

Apr 1, 2025Apr 1 8:44 PMRodman David Malcom
Proposed Sale
55,771$15.76$879.0K

View →

Jan 13, 2025Jan 13 11:34 PMCongleton Jon
Proposed Sale
18,333$9.06$166.1K

View →

Jan 13, 2025Jan 13 11:21 PMLevy Adam Scott
Proposed Sale
10,757$9.10$97.9K

View →

Nov 6, 2024Nov 6 11:43 PMRodman David Malcom
Proposed Sale
25,482$15.03$383.1K

View →

Oct 11, 2024Oct 11 8:54 PMCongleton Jon
Proposed Sale
15,271$13.52$206.4K

View →

Oct 11, 2024Oct 11 8:48 PMLevy Adam Scott
Proposed Sale
10,757$13.57$146.0K

View →

Nov 11, 2024Rodman David Malcom
Proposed Sale
5,026$15.00$75.4K

View →

← Previous

Page 4 of 4

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 13, 2026May 14 1:42 AMDavid Malcom RodmanChief Medical Officer
Option Exercise
7,707$14.2587,501(D)

View →

May 12, 2026May 14 1:42 AMDavid Malcom RodmanChief Medical Officer
Option Exercise
6,348$1.0812,698(D)

View →

May 11, 2026May 14 1:42 AMDavid Malcom RodmanChief Medical Officer
Option Exercise
2,171$16.0019,535(D)

View →

Apr 17, 2026Apr 21 10:59 PMDavid Malcom RodmanChief Medical Officer
Option Exercise
416$15.444,584(D)

View →

Apr 13, 2026Apr 16 1:45 AMDavid Malcom RodmanChief Medical Officer
Option Exercise
14,058$14.2591,667(D)

View →

Apr 9, 2026Apr 14 1:13 AMDavid Malcom RodmanChief Medical Officer
Option Exercise
2,170$16.0021,706(D)

View →

Mar 31, 2026Apr 2 10:53 PMDaphne KarydasDirector
Option Exercise
3,000$12.0241,000(D)

View →

Mar 17, 2026Mar 17 8:51 PMDavid Malcom RodmanChief Medical Officer
Option Exercise
417$15.445,000(D)

View →

Mar 13, 2026Mar 16 9:20 PMDavid Malcom RodmanChief Medical Officer
Option Exercise
7,709$14.2595,834(D)

View →

Mar 12, 2026Mar 16 9:20 PMDavid Malcom RodmanChief Medical Officer
Option Exercise
6,348$1.0825,395(D)

View →

Mar 9, 2026Mar 10 9:48 PMDavid Malcom RodmanChief Medical Officer
Option Exercise
2,171$16.0023,876(D)

View →

Feb 19, 2026Feb 21 12:49 AMRA CAPITAL MANAGEMENT, L.P.Director
Grant/Award
8,300$28.068,300(I)

View →

Feb 19, 2026Feb 21 12:47 AMJon CongletonDirector, Chief Executive Officer
Grant/Award
187,900$28.06187,900(D)

View →

Feb 19, 2026Feb 21 12:47 AMGlenn SblendorioDirector
Grant/Award
8,300$28.068,300(D)

View →

Feb 19, 2026Feb 21 12:47 AMAlexander M GoldDirector
Grant/Award
8,300$28.068,300(D)

View →

Feb 19, 2026Feb 21 12:47 AMDaphne KarydasDirector
Grant/Award
8,300$28.068,300(D)

View →

Feb 19, 2026Feb 21 12:47 AMBrian Taylor SlingsbyDirector, 10% Owner
Grant/Award
8,300$28.068,300(D)

View →

Feb 19, 2026Feb 21 12:47 AMBrian Taylor SlingsbyDirector, 10% Owner
Other (J)
8,300$28.068,300(I)

View →

Feb 19, 2026Feb 21 12:47 AMBrian Taylor SlingsbyDirector, 10% Owner
Other (J)
8,300$28.060(D)

View →

Feb 19, 2026Feb 21 12:47 AMSrinivas AkkarajuDirector, 10% Owner
Grant/Award
8,300$28.068,300(D)

View →

Page 1 of 2

Next →